Chief Medical Officer
Dr. Walker brings to Accera over 20 years of experience in the global biopharmaceutical industry, her wealth of expertise in neurology drug development is invaluable. Prior to joining Accera, she was with QuintilesIMS where she held the position of Vice President of Product Development Advisory Services, providing leadership for the global clinical development of drugs in the areas of neurology and pain. Prior to QuintilesIMS, Dr. Walker served as Senior Director of Medical Affairs at Teva Neuroscience, a division of Teva Pharmaceuticals. Before Teva Neuroscience, Dr. Walker held leadership roles in global product and global clinical development in neurology at Serono International (Merck KGaA). Dr. Walker continues to serve on the boards of Great Lakes Neuroscience and the pharmaceutical advisory board of the non-profit Accelerated Cure Project. A Fellow of the Royal College of Physicians and Surgeons of Canada, Dr. Walker received her medical degree from the University of Montréal and completed her residency in neurology at the University of Western Ontario.